139 related articles for article (PubMed ID: 18995189)
1. Automated (11)C-PiB standardized uptake value ratio.
Raniga P; Bourgeat P; Fripp J; Acosta O; Villemagne VL; Rowe C; Masters CL; Jones G; O'Keefe G; Salvado O; Ourselin S
Acad Radiol; 2008 Nov; 15(11):1376-89. PubMed ID: 18995189
[TBL] [Abstract][Full Text] [Related]
2. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
[TBL] [Abstract][Full Text] [Related]
3. Comparison of MR-less PiB SUVR quantification methods.
Bourgeat P; Villemagne VL; Dore V; Brown B; Macaulay SL; Martins R; Masters CL; Ames D; Ellis K; Rowe CC; Salvado O; Fripp J;
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S159-66. PubMed ID: 25257985
[TBL] [Abstract][Full Text] [Related]
4. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
Edison P; Carter SF; Rinne JO; Gelosa G; Herholz K; Nordberg A; Brooks DJ; Hinz R
Neuroimage; 2013 Apr; 70():423-33. PubMed ID: 23261639
[TBL] [Abstract][Full Text] [Related]
5. Head-to-head comparison of 11C-PiB and 18F-FC119S for Aβ imaging in healthy subjects, mild cognitive impairment patients, and Alzheimer's disease patients.
Byun BH; Kim BI; Park SY; Ko IO; Lee KC; Kim KM; Kim YK; Lee JY; Bu SH; Kim JH; Chi DY; Ha JH; Lim SM
Medicine (Baltimore); 2017 Mar; 96(12):e6441. PubMed ID: 28328855
[TBL] [Abstract][Full Text] [Related]
6. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.
Thurfjell L; Lilja J; Lundqvist R; Buckley C; Smith A; Vandenberghe R; Sherwin P
J Nucl Med; 2014 Oct; 55(10):1623-8. PubMed ID: 25146124
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
Hatashita S; Wakebe D
J Alzheimers Dis; 2017; 57(3):765-773. PubMed ID: 28304292
[TBL] [Abstract][Full Text] [Related]
8. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
9. Spline based inhomogeneity correction for 11C-PIB PET segmentation using expectation maximization.
Raniga P; Bourgeat P; Villemagne V; O'Keefe G; Rowe C; Ourselin S
Med Image Comput Comput Assist Interv; 2007; 10(Pt 1):228-35. PubMed ID: 18051063
[TBL] [Abstract][Full Text] [Related]
10. Increased Pittsburgh Compound-B Accumulation in the Subcortical White Matter of Alzheimer's Disease Brain.
Wakabayashi Y; Ishii K; Hosokawa C; Hyodo T; Kaida H; Yamada M; Yagyu Y; Tsurusaki M; Kozuka T; Sugimura K; Murakami T
Kobe J Med Sci; 2017 Mar; 62(5):E136-E141. PubMed ID: 28289271
[TBL] [Abstract][Full Text] [Related]
11. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
[TBL] [Abstract][Full Text] [Related]
12. Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET.
Rosario BL; Weissfeld LA; Laymon CM; Mathis CA; Klunk WE; Berginc MD; James JA; Hoge JA; Price JC
Neuroimage; 2011 Apr; 55(3):933-41. PubMed ID: 21195782
[TBL] [Abstract][Full Text] [Related]
13. Performance of 11C-Pittsburgh Compound B PET Binding Potential Images in the Detection of Amyloid Deposits on Equivocal Static Images.
Hosokawa C; Ishii K; Kimura Y; Hyodo T; Hosono M; Sakaguchi K; Usami K; Shimamoto K; Yamazoe Y; Murakami T
J Nucl Med; 2015 Dec; 56(12):1910-5. PubMed ID: 26359262
[TBL] [Abstract][Full Text] [Related]
14. Comparison of [
Lowe VJ; Lundt E; Knopman D; Senjem ML; Gunter JL; Schwarz CG; Kemp BJ; Jack CR; Petersen RC
Neuroimage Clin; 2017; 16():295-302. PubMed ID: 28856092
[TBL] [Abstract][Full Text] [Related]
15. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
[TBL] [Abstract][Full Text] [Related]
16. Automated PET-only quantification of amyloid deposition with adaptive template and empirically pre-defined ROI.
Akamatsu G; Ikari Y; Ohnishi A; Nishida H; Aita K; Sasaki M; Yamamoto Y; Sasaki M; Senda M
Phys Med Biol; 2016 Aug; 61(15):5768-80. PubMed ID: 27405579
[TBL] [Abstract][Full Text] [Related]
17. MR-less surface-based amyloid assessment based on 11C PiB PET.
Zhou L; Salvado O; Dore V; Bourgeat P; Raniga P; Macaulay SL; Ames D; Masters CL; Ellis KA; Villemagne VL; Rowe CC; Fripp J;
PLoS One; 2014; 9(1):e84777. PubMed ID: 24427295
[TBL] [Abstract][Full Text] [Related]
18. Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements.
McNamee RL; Yee SH; Price JC; Klunk WE; Rosario B; Weissfeld L; Ziolko S; Berginc M; Lopresti B; Dekosky S; Mathis CA
J Nucl Med; 2009 Mar; 50(3):348-55. PubMed ID: 19223409
[TBL] [Abstract][Full Text] [Related]
19. Brain Amyloid PET Tracer Delivery is Related to White Matter Integrity in Patients with Mild Cognitive Impairment.
Brown EE; Rashidi-Ranjbar N; Caravaggio F; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Fischer CE; Flint A; Mah L; Herrmann N; Bowie CR; Voineskos AN; Graff-Guerrero A;
J Neuroimaging; 2019 Nov; 29(6):721-729. PubMed ID: 31270885
[TBL] [Abstract][Full Text] [Related]
20. Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species.
Oliveira F; Leuzy A; Castelhano J; Chiotis K; Hasselbalch SG; Rinne J; Mendonça A; Otto M; Lleó A; Santana I; Johansson J; Anderl-Straub S; Arnim C; Beer A; Blesa R; Fortea J; Sanna-Kaisa H; Portelius E; Pannee J; Zetterberg H; Blennow K; Moreira AP; Abrunhosa A; Nordberg A; Castelo-Branco M
Neuroimage Clin; 2018; 20():603-610. PubMed ID: 30186764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
